Corrections

The article, “End-Stage Renal Disease: Symptom Management and Advance Care Planning” (April 1, 2012, page 705), contained two errors. In Table 3 on page 708, the dosage for fentanyl was incorrectly listed as 12.5 mg. The correct dosage for fentanyl is 12.5 mcg intravenously or subcutaneously every two hours as needed. The brand name Duragesic was also incorrectly added to fentanyl in Table 3, and in several locations throughout the article. Fentanyl should have been listed without a brand name. The online version of this article has been corrected.